Cargando…
T Lymphocytes as Targets for SARS-CoV-2
Despite numerous data on the absence or weak expression of the main functional receptor of SARS-CoV-2 angiotensin-converting enzyme 2 (ACE2) by T cells, it was recently demonstrated that the new coronavirus can efficiently infect T lymphocytes. Here, we analyze the data on the alternative (ACE2-inde...
Autor principal: | Kuklina, Elena M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pleiades Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201263/ https://www.ncbi.nlm.nih.gov/pubmed/35790412 http://dx.doi.org/10.1134/S0006297922060086 |
Ejemplares similares
-
SARS-CoV-2-triggered lymphocytic colitis
por: Nassar, Islam Osama, et al.
Publicado: (2021) -
Management of patients with chronic lymphocytic leukemia during the SARS-CoV-2 pandemic
por: Mihaila, Romeo Gabriel
Publicado: (2021) -
SARS-CoV, MERS-CoV and SARS-CoV-2 infections in pregnancy and fetal development
por: de Souza Silva, Guilherme Antonio, et al.
Publicado: (2020) -
Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV
por: Aherfi, Sarah, et al.
Publicado: (2021) -
Atypical lymphocyte morphology in SARS-CoV-2 infection
por: El Jamal, Siraj M., et al.
Publicado: (2020)